Trial intelligence / Profile preview

Four versus eight weeks of Maviret-based treatment for chronic hepatitis C in adults under 50 without significant liver fibrosis

2017-005179-21Phase 4Terminated

Sponsor

University Hospital Odense

Start

Jan 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1